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Abstract. As one year is approaching since the beginning 
of the Coronavirus disease 2019 (COVID‑19) pandemic, it 
is important to acknowledge the detrimental effect that it is 
having on mental health at the individual, societal and public 
health levels. The current review presents the direct and indirect 
psychological impact of COVID‑19 on the general public, as 
well as on vulnerable groups, including the elderly, the young, 
healthcare professionals, people with pre‑existing mental 
health issues, those infected by COVID‑19, homeless people 
and refugees. Important findings are discussed in the present 
review, including the social stigma in older people associated 
with portraying COVID‑19 as the disease of the elderly, and 
the limited psychological impact of COVID‑19 in the severely 
mentally ill, alongside the response of the mental healthcare 
systems globally to this unparalleled public health crisis. The 
important lessons to be learnt so far can help formulate indi‑
vidual mental health recommendations, as well as improved 
intervention and prevention public health strategies.
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coronavirus‑2 (SARS‑CoV‑2) as a pandemic (1). SARS‑CoV‑2 
constitutes a zoonotic virus that can be transmitted from 
animals, such as bats, to humans and, once adapted to do 
so, between humans via airborne droplets and aerosols. Due 
to the fact that SARS‑CoV‑2 spike protein exhibits high 
binding affinity for angiotensin‑converting‑enzyme 2 (ACE2) 
receptors that are highly expressed in the respiratory tract, 
particularly in epithelial lung cells, COVID‑19 may lead 
to atypical pneumonia with rapid respiratory deterioration. 
ACE2 receptors can also be traced in mucosal intestinal cells, 
endothelial cells of veins and arteries including heart cells, 
epithelial renal and cerebral neuronal cells, thus explaining 
COVID‑19 extra‑pulmonary symptoms, such as diarrhea, 
nausea and vomiting, chest pain and heart failure, renal injury, 
headache and confusion. COVID‑19 risk is higher among frail 
elderly subjects, especially males, with a previous history of 
diabetes and hypertension treated with ACE inhibitors and 
angiotensin II type‑I receptor blockers, as these drugs increase 
ACE2 receptors' expression (2).
Although psychiatric and neuropsychiatric clinical mani‑
festations of COVID‑19 are well‑established (3) and insight 
into potential infectious and post‑infectious pathogenetic 
mechanisms linking SARS‑CoV‑2 to acute and long term 
neuropsychiatric complications is continuously updated (4), it 
is the direct and indirect psychological and social effects of the 
ongoing COVID‑19 pandemic, comprising the most prolonged 
global crisis since World War II (5,6), together with the subse‑
quent disruptions of mental, neurological and substance use 
(MNS) services (7) that mainly compromise public mental 
health. Very recent meta‑analytic data exhibited that mental 
health problems are common in different populations with an 
overall pooled prevalence of depression, anxiety, distress, and 
insomnia 31.4, 31.9, 41.1 and 37.9%, respectively. In regards 
with population subgroups, patients with noninfectious chronic 
disease (such as cancer or diabetes) had the highest prevalence 
of depression of all groups, and high rates of anxiety and 
distress. In addition, people who were quarantined, patients 
suspected of COVID‑19 infection, and physicians and nurses 
had high prevalence of depression, anxiety, distress and 
insomnia (8).
2. Impact of COVID‑19 pandemic on mental health of the 
general population
Even though COVID‑19 is the third major coronavirus 
outbreak over the past 20 years that has had substantial socio‑
economic impact, it is the first in the 21st century to affect 
countries across all continents except Antarctica (2). Distress, 
uncertainty and unpredictability due to lack of endpoint of the 
COVID‑19 pandemic while treatment is still not in sight, have 
led to the emergence of mental health issues, such as panic, 
anxiety and depression (9) and in combination with treatment 
delays of serious chronic diseases have led to triggering of 
somatic symptoms and exacerbation of common patholo‑
gies (10‑12). Moreover, repeated media images of severely ill 
people, dead bodies and coffins and knowledge that people 
may not be able to say goodbye to their dying loved ones 
have magnified social distress (13). Apart from that, the unfa‑
miliarity with strict quarantine measures (14) that infringe 
on personal freedoms (15,16) combined with the widening 
economic crisis and unemployment mainly affecting those 
with informal, daily wage jobs, which include a substantial 
proportion of the workforce in lower‑income countries (17), 
have resulted in various deleterious ways of coping with daily 
stressors, such as alcohol, drug and tobacco abuse, potentially 
addictive behaviours, such as online gaming and gambling, 
and rise in rates of domestic violence and sexual abuse (18,19).
3. Impact of COVID‑19 pandemic on mental health of the 
elderly
Mental health problems and, especially, depressive symptoms 
are common in the elderly (20,21). Due to the fact that in the 
COVID‑19 era mental health care provision has shifted to tele‑
medicine this age group seems to be disproportionally affected 
as most elderly individuals not only have limited access or lack 
ability to use smart phones and internet services, but also due 
to ongoing mass quarantines and public transport restrictions 
cannot reach their outpatient clinics in order to obtain their 
monthly prescriptions (22). This results in perception of lack 
of treatment and exacerbation of pre‑existing psychiatric 
symptoms. Apart from that, the burden of social isolation is 
worsened when hospitalization is required, as most hospitals in 
affected areas do not allow visitors (19). Likewise, older adults 
without pre‑existing psychiatric disorders appear extremely 
susceptible to develop mental health issues as, especially 
those with underlying health conditions, comprise the most 
vulnerable age group for life‑threatening complications and 
death from COVID‑19, thus are currently extremely worried 
about being infected with the virus and not having access to 
appropriate care (13). Rather disturbingly, public media have 
portrayed COVID‑19 as a disease of the elderly leading to 
social stigma, negative stereotypes and age‑based discrimina‑
tion against older individuals with outcomes ranging from 
increased isolation to violations to their right to health and life 
on an equal basis with others, causing additional distress not 
only to them but also to their family and caregivers (23).
In regards with the relation of mental illness and morbidity 
and mortality of COVID‑19 infection in elderly populations, 
a study in Caucasian older patients with COVID‑19 showed 
that functional decline was an independent risk factor and a 
strong predictor of mortality (24), while meta‑analytic data 
showed that dementia in older adults is associated with an 
enhanced risk of mortality from COVID‑19 infection (25). 
It is also important to consider the psychological impact of 
hospital stay in elderly COVID‑19 intensive care unit (ICU) 
survivors discharged alive, which has been associated with 
cognitive impairment and poor mental health outcomes, while 
the patient's family members, especially the older ones, appear 
to also suffer significant psychological repercussions (26).
4. Impact of COVID‑19 pandemic on mental health of 
children, adolescents and young people
Due to their rapidly developing and sensitive to environmental 
adversities brain architecture, children's mental health 
development appears extremely vulnerable in the COVID‑19 
era, as children are exposed to chronic stress conditions, such 
as forced isolation from peers due to social distancing and 
shelter at home laws and worries about the health and financial 
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status of their relatives (19). Moreover, due to the fact that 
most mental health conditions develop during adolescence 
and young adulthood, individuals in these age groups also 
appear susceptible to developing mental health symptoms due 
to ongoing stressors, such as school and university closures, 
loss of routine and social connection and diminishment of 
economic prospects (13). Loneliness, specifically, is strongly 
associated with mental health problems, such as depression 
symptoms in girls and social anxiety in boys. Moreover, the 
length of loneliness appears to be a predictor of future mental 
health problems as children who had experienced enforced 
isolation or quarantine were five times more likely to require 
mental health service input and experienced higher levels of 
posttraumatic stress. This is of particular relevance in the 
COVID‑19 context, as politicians in different countries consider 
the length of time that schools should remain closed and the 
implementation of social distancing within schools (27). 
Finally, mental health risks secondary to COVID‑19 are 
expected to disproportionately affect children and adolescents 
who are already disadvantaged, such as those with intellectual 
disabilities who already struggle to understand environmental 
cues and may struggle to appreciate the need for current 
restrictions, thus exacerbating their agitation and anxiety (19).
5. Impact of COVID‑19 pandemic on mental health of 
health care professionals (HCPs)
During the COVID‑19 outbreak, frontline HCPs in hospitals 
and long‑term care facilities are at a significant risk of adverse 
mental health outcomes as they have been confronted with 
mounting challenges that have not been faced before (28). 
Extreme workloads, shortages of protective equipment or their 
extensive use (29), lack of disaster training and difficult deci‑
sions potentially resulting in deaths that might not have occurred 
under normal circumstances, fear of becoming infected or 
spread infection to their relatives, witnessing patients' deaths, 
separation from families and stigmatization by their commu‑
nities (30) have resulted in high rates of anxiety, depression, 
insomnia, distress, somatization and obsessive‑compulsive 
symptoms (31,32) and increased risk of developing post‑
traumatic stress disorder and posttraumatic stress symptoms 
(PTSS) (33). Nurses are more vulnerable compared to doctors. 
Additional work related factors that increase psychological 
adverse outcomes include forced redeployment to look after 
affected patients, being less experienced, in part time employ‑
ment, or in increased contact with affected patients. Personal 
risk factors, such as staff with children at home or infected 
family members, female gender, single or social isolation or 
comorbid physical or psychiatric disorders further compro‑
mise HCPs' mental health in the COVID‑19 era (34).
6. Impact of COVID‑19 pandemic on mental health of 
people with pre‑existing mental health conditions
Patients with pre‑existing mental health issues appear 
extremely vulnerable to relapsing during the COVID‑19 
pandemic, as SARS‑CoV‑2 can exacerbate underlying 
psychiatric symptoms, such as anxiety, depression, panic, 
delirium, psychosis and suicidality. Moreover, patients 
with serious psychiatric disorders, such as schizophrenia, 
who are commonly socioeconomically disadvantaged, are 
further compromised by stay‑at‑home orders and subsequent 
reduced access to employment opportunities, thus worsening 
their economic distress (19). However, at a time when they 
are suffering more distress, mentally ill patients experience 
significant reductions in availability of care. More specifically, 
according to a recent WHO assessment, COVID‑19 pandemic 
has resulted in significant disruptions of MNS services, 
such as school and work‑related mental health programs, 
services for children, adolescents and older adults, interven‑
tions for caregivers, psychotherapy/counselling/psychosocial 
interventions, home or community outreach services, critical 
harm reduction services, mental health interventions during 
antenatal and postnatal period, suicide and overdose preven‑
tion and management programs, opioid agonist maintenance 
treatment of opioid dependence and management of emer‑
gency MNS manifestations (6). Finally, immature discharge 
from psychiatric units may lead to relapse, suicidal behavior, 
anxiety, depression and post‑traumatic incidents, including 
insomnia (18).
7. Impact of COVID‑19 pandemic on individuals with and 
without mental disorders prior to COVID‑19 pandemic
So far, most evidence on the impact of the COVID‑19 pandemic 
on individuals with and without preexisting mental health 
conditions is based on cross‑sectional and not on longitudinal 
studies with comparable prepandemic information. Among 
the few conducted longitudinal studies, McGinty et al (35) and 
Pierce et al (36) reported a rise in psychological distress among 
US and UK adults, respectively, in the COVID‑19 compared to 
the pre‑COVID‑19 era. Furthermore, Pan et al utilizing longi‑
tudinal data from three existing Dutch psychiatry case‑control 
cohorts, including people with and without mental health 
disorders (depressive, anxiety, or obsessive‑compulsive 
disorders) revealed that the levels of depressive symptoms, 
anxiety, worry, and loneliness increased in people with no 
or less severe mental health disorders during the COVID‑19 
pandemic (37). In contrast, changes of symptom levels were 
minimal or even negative in individuals with the most severe 
and chronic mental health disorders. Similarly, Pinkham et al 
could not find significant changes in mood experiences, 
psychotic symptoms or sleep duration among participants 
diagnosed with severe mental illnesses, such as schizophrenia 
or schizoaffective disorder or bipolar disorder (I or II) with or 
without psychotic features or major depression with psychotic 
features in the COVID‑19 era. Rather surprisingly participants 
reported a significant increase in well‑being post‑pandemic 
onset (38). Thus, from the aforementioned studies, it seems 
that patients with pre‑existing mental health issues coped 
remarkably well in the COVID‑19 pandemic. As potential 
explanations of these findings, it has been suggested that with 
transmission mitigation strategies in place, individuals with 
severe mental health disorders might experience some sense 
of relaxation as their world and habits became more in sync 
with the quarantined society. Moreover, staying at home could 
help them build a structured and fixed daily routine, which has 
been expressed as a preferable setting to provide a feeling of 
safety (37). Furthermore, there are factors that seem to offer 
protection against the detrimental effects of stress. This has 
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been termed ‘resilience’, i.e., the ability to maintain or quickly 
recover mental health during and after times of adversity (9).
8. Impact of COVID‑19 pandemic on mental health of 
people who have been infected with SARS‑CoV‑2
Physical isolation from family members or loved ones 
during quarantine or hospital stay can produce psychological 
instability among people infected with SARS‑CoV‑2 (18). 
Moreover, high rates of PTSS are evident among patients 
that have recovered from COVID‑19 and were discharged 
from hospital (39). Apart from that, those admitted in ICUs 
often experience post‑intensive‑care syndrome that manifests 
with cognitive, psychological, and neurological symptoms or 
dysexecutive syndrome after ICU discharge (40). Furthermore, 
in a recently published study the risk of depression was 
higher among COVID‑19 patients (41). This could be due to 
the coronavirus affecting the brain directly or indirectly by 
inducing a massive cytokine response harming the brain (3). 
Finally, based on prior experience with SARS‑CoV‑1 infection 
where rates of depression were higher 1 month and 1 year after 
recovery, huge after‑wave of patients suffering from depres‑
sion are expected in case of COVID‑19, as well (42).
9. Impact of COVID‑19 pandemic on mental health of 
homeless people and refugees
Homeless people and refugees most often live in environ‑
ments that are conducive to a disease epidemic, such as 
COVID‑19, as they stay in congregate living settings, such 
as shelters, halfway houses, encampments or abandoned 
buildings and lack regular access to basic hygiene supplies 
or showering facilities. Moreover, many of them suffer from 
chronic mental and physical conditions, engage in high rates of 
substance abuse and have less access to health care. Although 
large prospective studies are missing, their increased risk of 
COVID‑19 infection seems to generate high levels of stress 
that could exacerbate existing mental health conditions or 
induce new ones (43,44).
10. How mental healthcare systems responded to the 
COVID‑19 crisis
Mental Healthcare systems have been facing unprecedented 
challenges during the pandemic. A recent survey by the World 
Health Organisation reported that COVID‑19 has disrupted or 
halted critical mental health services in 93% of countries world‑
wide while the demand for mental health is increasing (45). The 
WHO survey which was conducted in 130 countries globally 
highlighted disruptions in mental health services for vulner‑
able people (such as children and adolescents, older adults, 
antenatal services), in psychotherapy, critical harm reduction, 
opioid maintenance treatment and emergency services. WHO 
also reports that providing personalised medicine and crisis 
support during the COVID‑19 era is far more difficult in larger 
mental health institutions, than in community settings, which 
in turn increases the risk of inequity of care in people with 
psychosocial and intellectual disabilities (46).
In order to overcome MNS service disruptions, most 
countries (70%) utilized tele‑medicine /tele‑therapy in order 
to replace in person consultations, 67.7% established helplines 
for mental health and psychosocial support, 65.4% specific 
measures for infection prevention and control in mental health 
services, while 44.6% trained COVID‑19 health care providers 
in basic psychosocial skills, 44.6% discharged or redirected 
patients to alternate health care facilities 33.1% utilized home 
or community outreach services and 20.8% recruited counsel‑
lors (6). Moreover, concerning HCP many hospitals utilized 
caregiver support strategies, such as providing a place of rest in 
order to isolate staff from family, developing video records to 
share with family, training on personal protective equipment, 
provision of security to manage agitated/aggressive patients 
and leisure activities (19).
COVID‑19 crisis is an opportunity not only to identify 
system failures but also to improve and build health care 
systems that operate better during crises. On a healthcare 
policy level it is important to ensure clarity of communication 
between authorities and the public (including services users) 
and provide clear procedures to safeguard psychological well 
Figure 1. COVID‑19 recovery framework, perspectives and recommended actions. COVID‑19, coronavirus disease 2019; SARS‑CoV‑2, severe acute respira‑
tory syndrome coronavirus‑2.
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being from the challenges arising from the pandemic and the 
impact of social distancing and isolation measures. Finally, it 
is time that countries respond with increased funding and staff 
capacities regarding (the chronic underfunded) mental health 
services, especially given the anticipated increased pressure 
in the near future on national and international mental health 
services (45).
11. Future perspectives
Although COVID‑19 pandemic initially resulted in approxi‑
mately 1,000 new COVID‑19‑related listings per week on the 
PubMed.gov website (47), very few studies have addressed 
the practical matter of how psychiatric care should change as 
a consequence of the ongoing mental health tsunami (4,18). 
WHO has recently published operational guidances in order 
to maintain essential health services with specific focus on 
the younger, the elderly and those suffering from MNS disor‑
ders (48). Moreover, in a recent policy brief by the United 
Nations on the topic COVID‑19 and the need for action on 
mental health it was recommended that a whole‑of‑society 
approach should be applied in order to promote, protect and 
care for mental health, widespread availability of emergency 
mental health and psychosocial support should be ensured and 
recovery from COVID‑19 pandemic should be supported by 
building mental health services for the future (23). Apart from 
that, it is advised that governments and health officials must 
provide accurate information on the state of the pandemic, 
refute rumors in a timely manner, and reduce the impact of 
misinformation on the general public's emotional state. These 
high level activities result in a sense of public security and 
potential psychological benefits (49). Finally, six important roles 
for the psychiatrists have been identified: a) education of the 
public about the common psychological effects of a pandemic, 
b) motivating the public to adopt strategies for disease preven‑
tion and health promotion, c) integrating their services with 
available health care, d) teaching problem‑solving strategies 
to cope with the current crisis, e) empowering patients with 
COVID‑19 and their caregivers, and f) provision of mental 
health care to healthcare workers (50,51). Fig. 1 summarizes 
the responses of mental healthcare systems to the enormous 
mental health implications caused by COVID‑19, alongside 
the public health goals and future perspectives.
12. Conclusion
COVID‑19 pandemic has changed our lives dramatically. This 
unprecedented in size and duration and still ongoing global 
biothreat, which affects us all regardless of skin color, ethnicity 
and wealth (52), has already had a tremendous impact on 
mental health of the general population, but most importantly 
on the psychological well‑being of vulnerable groups, such 
as the mentally ill, frontline healthcare workers, the younger, 
the elderly and the most socioeconomically deprived. It is of 
utmost importance to acknowledge these consequences on the 
most exposed, as well as the huge strain on mental healthcare, 
and to identify healthcare system vulnerabilities during times 
of crisis. Given the probability of future COVID‑19 waves and 
potentially future pandemics, it is critical for policy makers 
to ensure that clear guidelines, effective communication 
channels and proactive protocols are prepared now to help 
alleviate the consequences of the pandemic crisis and the 
subsequent restrictive measures, so as to prevent the mental 
health tsunami in sight; all this while maintaining focus on 
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